Loading...

Roger Spragg

Title(s)Emeritus Professor, Medicine
SchoolHealth Sciences
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Wesleyan University, Middletown, CTBA1965Mathematics
    University of Rochester, Rochester, NYMD1969Medicine
    University of California, San Diego, San Diego, CA1969Internal Medicne
    NHLBI, NIH, Bethesda, MD1971Medicine
    University of California, San Diego, San Diego, CA1973Internal Medicine
    University of California, San Diego, San Diego, CA1975Pulmonary/Critical Care Medicine

    Collapse Research 
    Collapse Research Activities and Funding
    PATHOLOGY OF THE SURFACTANT SYSTEM OF THE MATURE LUNG
    NIH/NHLBI R13HL062421Aug 23, 1999 - Aug 22, 2000
    Role: Principal Investigator
    SURFACTANT PATHOLOGY IN THE MATURE LUNG
    NIH/NHLBI R13HL052526Sep 1, 1994 - Aug 31, 1995
    Role: Principal Investigator
    MECHANISMS OF LUNG CELL OXIDANT INJURY
    NIH/NHLBI R01HL036270Apr 1, 1986 - Mar 31, 1992
    Role: Principal Investigator
    SCOR IN ACUTE LUNG INJURY
    NIH/NHLBI P50HL023584Dec 1, 1978 - Nov 30, 2003
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Beitler JR, Sands SA, Loring SH, Owens RL, Malhotra A, Spragg RG, Matthay MA, Thompson BT, Talmor D. Quantifying unintended exposure to high tidal volumes from breath stacking dyssynchrony in ARDS: the BREATHE criteria. Intensive Care Med. 2016 Sep; 42(9):1427-36. PMID: 27342819; PMCID: PMC4992404 [Available on 09/01/17].
    2. Beitler JR, Thompson BT, Matthay MA, Talmor D, Liu KD, Zhuo H, Hayden D, Spragg RG, Malhotra A. Estimating dead-space fraction for secondary analyses of acute respiratory distress syndrome clinical trials. Crit Care Med. 2015 May; 43(5):1026-35. PMID: 25738857; PMCID: PMC4400228.
    3. Breen EC, Malloy JL, Tang K, Xia F, Fu Z, Hancock RE, Overhage J, Wagner PD, Spragg RG. Impaired pulmonary defense against Pseudomonas aeruginosa in VEGF gene inactivated mouse lung. J Cell Physiol. 2013 Feb; 228(2):371-9. PMID: 22718316; PMCID: PMC3484242.
    4. Kerr KM, Auger WR, Marsh JJ, Devendra G, Spragg RG, Kim NH, Channick RN, Jamieson SW, Madani MM, Manecke GR, Roth DM, Shragg GP, Fedullo PF. Efficacy of methylprednisolone in preventing lung injury following pulmonary thromboendarterectomy. Chest. 2012 Jan; 141(1):27-35. PMID: 21835900; PMCID: PMC3251267.
    5. Spragg RG, Taut FJ, Lewis JF, Schenk P, Ruppert C, Dean N, Krell K, Karabinis A, Günther A. Recombinant surfactant protein C-based surfactant for patients with severe direct lung injury. Am J Respir Crit Care Med. 2011 Apr 15; 183(8):1055-61. PMID: 21148720.
      View in: PubMed
    6. Spragg RG, Masys DR, Sergeant D, Lawrie T, Taut FJ. An informatics strategy to assure enrollment criteria compliance in studies of the critically ill. Contemp Clin Trials. 2010 Nov; 31(6):530-5. PMID: 20667511.
      View in: PubMed
    7. Spragg RG, Bernard GR, Checkley W, Curtis JR, Gajic O, Guyatt G, Hall J, Israel E, Jain M, Needham DM, Randolph AG, Rubenfeld GD, Schoenfeld D, Thompson BT, Ware LB, Young D, Harabin AL. Beyond mortality: future clinical research in acute lung injury. Am J Respir Crit Care Med. 2010 May 15; 181(10):1121-7. PMID: 20224063; PMCID: PMC2874454.
    8. Spragg RG, Taut FJH, Günther A, Rippin G. Surfactant replacement therapy in ARDS. Chest. 2009 Jul; 136(1):321-322. PMID: 19584221.
      View in: PubMed
    9. Taut FJ, Rippin G, Schenk P, Findlay G, Wurst W, Häfner D, Lewis JF, Seeger W, Günther A, Spragg RG. A Search for subgroups of patients with ARDS who may benefit from surfactant replacement therapy: a pooled analysis of five studies with recombinant surfactant protein-C surfactant (Venticute). Chest. 2008 Oct; 134(4):724-32. PMID: 18689599.
      View in: PubMed
    10. Spragg R. Surfactant for acute lung injury. Am J Respir Cell Mol Biol. 2007 Oct; 37(4):377-8. PMID: 17872593.
      View in: PubMed
    11. Davidson WJ, Dorscheid D, Spragg R, Schulzer M, Mak E, Ayas NT. Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis. Crit Care. 2006; 10(2):R41. PMID: 16542488; PMCID: PMC1550886.
    12. Lu Y, Song Z, Zhou X, Huang S, Zhu D, Yang C Bai X, Sun B, Spragg R. A 12-month clinical survey of incidence and outcome of acute respiratory distress syndrome in Shanghai intensive care units. Intensive Care Med. 2004 Dec; 30(12):2197-203. PMID: 15650866.
      View in: PubMed
    13. Spragg RG, Lewis JF, Walmrath HD, Johannigman J, Bellingan G, Laterre PF, Witte MC, Richards GA, Rippin G, Rathgeb F, Häfner D, Taut FJ, Seeger W. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med. 2004 Aug 26; 351(9):884-92. PMID: 15329426.
      View in: PubMed
    14. Spragg RG, Ponganis PJ, Marsh JJ, Rau GA, Bernhard W. Surfactant from diving aquatic mammals. J Appl Physiol (1985). 2004 May; 96(5):1626-32. PMID: 14688033.
      View in: PubMed
    15. Spragg RG. Acute lung injury in 2003. Acta Pharmacol Sin. 2003 Dec; 24(12):1288-91. PMID: 14653959.
      View in: PubMed
    16. Spragg RG, Lewis JF, Wurst W, Häfner D, Baughman RP, Wewers MD, Marsh JJ. Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant. Am J Respir Crit Care Med. 2003 Jun 01; 167(11):1562-6. PMID: 12649125.
      View in: PubMed
    17. Li J, Marsh JJ, Spragg RG. Effect of CTP:phosphocholine cytidylyltransferase overexpression on the mouse lung surfactant system. Am J Respir Cell Mol Biol. 2002 Jun; 26(6):709-15. PMID: 12034570.
      View in: PubMed
    18. Devendra G, Spragg RG. Lung surfactant in subacute pulmonary disease. Respir Res. 2002; 3:19. PMID: 11980588; PMCID: PMC107848.
    19. Spragg RG. The future of surfactant therapy for patients with acute lung injury - new requirements and new surfactants. Biol Neonate. 2002; 81 Suppl 1:20-4. PMID: 12011562.
      View in: PubMed
    20. Spragg RG, Lewis JF. Pathology of the surfactant system of the mature lung: second San Diego conference. Am J Respir Crit Care Med. 2001 Jan; 163(1):280-2. PMID: 11208658.
      View in: PubMed
    21. Spragg RG. Surfactant replacement therapy. Clin Chest Med. 2000 Sep; 21(3):531-41, ix. PMID: 11019725.
      View in: PubMed
    22. Spragg RG, Levin D. ARDS and the search for meaningful subgroups. Intensive Care Med. 2000 Jul; 26(7):835-7. PMID: 10990094.
      View in: PubMed
    23. Permpikul C, Wang HY, Kriett J, Konopka RG, Moser KM, Spragg RG. Reperfusion lung injury after unilateral pulmonary artery occlusion. Respirology. 2000 Jun; 5(2):133-40. PMID: 10894102.
      View in: PubMed
    24. Spragg RG, Smith RM, Harris K, Lewis J, Häfner D, Germann P. Effect of recombinant SP-C surfactant in a porcine lavage model of acute lung injury. J Appl Physiol (1985). 2000 Feb; 88(2):674-81. PMID: 10658037.
      View in: PubMed
    25. Spragg RG, Li J. Effect of phosphocholine cytidylyltransferase overexpression on phosphatidylcholine synthesis in alveolar type II cells and related cell lines. Am J Respir Cell Mol Biol. 2000 Jan; 22(1):116-24. PMID: 10615073.
      View in: PubMed
    26. Lewis J, McCaig L, Häfner D, Spragg R, Veldhuizen R, Kerr C. Dosing and delivery of a recombinant surfactant in lung-injured adult sheep. Am J Respir Crit Care Med. 1999 Mar; 159(3):741-7. PMID: 10051245.
      View in: PubMed
    27. Spragg RG. Surfactant therapy in acute respiratory distress syndrome. Biol Neonate. 1998 Sep; 74 Suppl 1:15-20. PMID: 9730587.
      View in: PubMed
    28. Dresselhaus TR, Luck J, Wright BC, Spragg RG, Lee ML, Bozzette SA. Analyzing the time and value of housestaff inpatient work. J Gen Intern Med. 1998 Aug; 13(8):534-40. PMID: 9734790.
      View in: PubMed
    29. Artigas A, Bernard GR, Carlet J, Dreyfuss D, Gattinoni L, Hudson L, Lamy M, Marini JJ, Matthay MA, Pinsky MR, Spragg R, Suter PM. The American-European Consensus Conference on ARDS, part 2: Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome. Am J Respir Crit Care Med. 1998 Apr; 157(4 Pt 1):1332-47. PMID: 9563759.
      View in: PubMed
    30. Artigas A, Bernard GR, Carlet J, Dreyfuss D, Gattinoni L, Hudson L, Lamy M, Marini JJ, Matthay MA, Pinsky MR, Spragg R, Suter PM. The American-European Consensus Conference on ARDS, part 2. Ventilatory, pharmacologic, supportive therapy, study design strategies and issues related to recovery and remodeling. Intensive Care Med. 1998 Apr; 24(4):378-98. PMID: 9609420.
      View in: PubMed
    31. Hopkins SR, Schoene RB, Henderson WR, Spragg RG, West JB. Sustained submaximal exercise does not alter the integrity of the lung blood-gas barrier in elite athletes. J Appl Physiol (1985). 1998 Apr; 84(4):1185-9. PMID: 9516183.
      View in: PubMed
    32. Gregory TJ, Steinberg KP, Spragg R, Gadek JE, Hyers TM, Longmore WJ, Moxley MA, Cai GZ, Hite RD, Smith RM, Hudson LD, Crim C, Newton P, Mitchell BR, Gold AJ. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 1997 Apr; 155(4):1309-15. PMID: 9105072.
      View in: PubMed
    33. Hopkins SR, Schoene RB, Henderson WR, Spragg RG, Martin TR, West JB. Intense exercise impairs the integrity of the pulmonary blood-gas barrier in elite athletes. Am J Respir Crit Care Med. 1997 Mar; 155(3):1090-4. PMID: 9116992.
      View in: PubMed
    34. Spragg RG, Smith RM. Pathology of the surfactant system of the mature lung. Am J Respir Crit Care Med. 1997 Feb; 155(2):756-60. PMID: 9032225.
      View in: PubMed
    35. Floros J, DiAngelo S, Koptides M, Karinch AM, Rogan PK, Nielsen H, Spragg RG, Watterberg K, Deiter G. Human SP-A locus: allele frequencies and linkage disequilibrium between the two surfactant protein A genes. Am J Respir Cell Mol Biol. 1996 Oct; 15(4):489-98. PMID: 8879183.
      View in: PubMed
    36. Ahuja A, Oh N, Chao W, Spragg RG, Smith RM. Inhibition of the human neutrophil respiratory burst by native and synthetic surfactant. Am J Respir Cell Mol Biol. 1996 May; 14(5):496-503. PMID: 8624255.
      View in: PubMed
    37. Pappert D, Gilliard N, Heldt G, Merritt TA, Wagner PD, Spragg RG. Effect of N-nitroso-N-methylurethane on gas exchange, lung compliance, and surfactant function of rabbits. Intensive Care Med. 1996 Apr; 22(4):345-52. PMID: 8708173.
      View in: PubMed
    38. Hastings RH, Summers-Torres D, Cheung TC, Ditmer LS, Petrin EM, Burton DW, Spragg RG, Li J, Deftos LJ. Parathyroid hormone-related protein, an autocrine regulatory factor in alveolar epithelial cells. Am J Physiol. 1996 Mar; 270(3 Pt 1):L353-61. PMID: 8638727.
      View in: PubMed
    39. Chao W, Spragg RG, Smith RM. Inhibitory effect of porcine surfactant on the respiratory burst oxidase in human neutrophils. Attenuation of p47phox and p67phox membrane translocation as the mechanism. J Clin Invest. 1995 Dec; 96(6):2654-60. PMID: 8675631.
      View in: PubMed
    40. Gilliard N, Pappert D, Spragg RG. Fractal analysis of surfactant deposition in rabbit lungs. J Appl Physiol (1985). 1995 Mar; 78(3):862-6. PMID: 7775330.
      View in: PubMed
    41. Gilliard N, Heldt GP, Loredo J, Gasser H, Redl H, Merritt TA, Spragg RG. Exposure of the hydrophobic components of porcine lung surfactant to oxidant stress alters surface tension properties. J Clin Invest. 1994 Jun; 93(6):2608-15. PMID: 8200999.
      View in: PubMed
    42. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, LeGall JR, Morris A, Spragg R. Report of the American-European Consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee. J Crit Care. 1994 Mar; 9(1):72-81. PMID: 8199655.
      View in: PubMed
    43. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994 Mar; 149(3 Pt 1):818-24. PMID: 7509706.
      View in: PubMed
    44. Spragg RG, Gilliard N, Richman P, Smith RM, Hite RD, Pappert D, Robertson B, Curstedt T, Strayer D. Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Chest. 1994 Jan; 105(1):195-202. PMID: 8031347.
      View in: PubMed
    45. Spragg R. Making progress. Intensive Care Med. 1994; 20(1):4-5. PMID: 8163756.
      View in: PubMed
    46. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, LeGall JR, Morris A, Spragg R. Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee. Intensive Care Med. 1994; 20(3):225-32. PMID: 8014293.
      View in: PubMed
    47. Montisano DF, Mann T, Spragg RG. H2O2 increases expression of pulmonary artery endothelial cell platelet-derived growth factor mRNA. J Appl Physiol (1985). 1992 Dec; 73(6):2255-62. PMID: 1490932.
      View in: PubMed
    48. Heldt GP, Merritt TA, Golembeski D, Gilliard N, Bloor C, Spragg R. Distribution of surfactant, lung compliance, and aeration of preterm rabbit lungs after surfactant therapy and conventional and high-frequency oscillatory ventilation. Pediatr Res. 1992 Mar; 31(3):270-5. PMID: 1561014.
      View in: PubMed
    49. Bozzette SA, Arcia J, Bartok AE, McGlynn LM, McCutchan JA, Richman DD, Spragg R, Spector SA. The impact of concomitant viral pathogens on the course of Pneumocystis carinii pneumonia. J Protozool. 1991 Nov-Dec; 38(6):183S-184S. PMID: 1667929.
      View in: PubMed
    50. Gilliard N, Pappert D, Merritt TA, Heldt G, Spragg RG. Radiolabeling of the hydrophobic components of lung surfactant with 3-(trifluoromethyl)-3-(m-[125I]iodophenyl)diazirine. Anal Biochem. 1991 Mar 02; 193(2):310-5. PMID: 1872476.
      View in: PubMed
    51. Spragg RG. DNA strand break formation following exposure of bovine pulmonary artery and aortic endothelial cells to reactive oxygen products. Am J Respir Cell Mol Biol. 1991 Jan; 4(1):4-10. PMID: 1846077.
      View in: PubMed
    52. Gilliard N, Richman PM, Merritt TA, Spragg RG. Effect of volume and dose on the pulmonary distribution of exogenous surfactant administered to normal rabbits or to rabbits with oleic acid lung injury. Am Rev Respir Dis. 1990 Mar; 141(3):743-7. PMID: 2310102.
      View in: PubMed
    53. Smith RM, Traber LD, Traber DL, Spragg RG. Pulmonary deposition and clearance of aerosolized alpha-1-proteinase inhibitor administered to dogs and to sheep. J Clin Invest. 1989 Oct; 84(4):1145-54. PMID: 2794051.
      View in: PubMed
    54. Merritt TA, Hallman M, Spragg R, Heldt GP, Gilliard N. Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome. Drugs. 1989 Oct; 38(4):591-611. PMID: 2684594.
      View in: PubMed
    55. Richman PS, Spragg RG, Robertson B, Merritt TA, Curstedt T. The adult respiratory distress syndrome: first trials with surfactant replacement. Eur Respir J Suppl. 1989 Mar; 3:109s-111s. PMID: 2742681.
      View in: PubMed
    56. Spragg RG, Richman P, Gilliard N, Merritt TA, Robertson B, Curstedt T. The use of exogenous surfactant to treat patients with acute high-permeability lung edema. Prog Clin Biol Res. 1989; 308:791-6. PMID: 2675070.
      View in: PubMed
    57. Merritt TA, Strayer DS, Hallman M, Spragg RD, Wozniak P. Immunologic consequences of exogenous surfactant administration. Semin Perinatol. 1988 Jul; 12(3):221-30. PMID: 3041605.
      View in: PubMed
    58. Moser KM, Smith RM, Spragg RG, Tisi GM. Intravenous administration of alpha-1-proteinase inhibitor in patients of PiZ and PiM phenotype. Preliminary report. Am J Med. 1988 Jun 24; 84(6A):70-4. PMID: 3260074.
      View in: PubMed
    59. Smith RM, Spragg RG. Production and administration to dogs of aerosols of alpha-1-proteinase inhibitor. Am J Med. 1988 Jun 24; 84(6A):48-51. PMID: 3260073.
      View in: PubMed
    60. Schneiderman LJ, Spragg RG. Ethical decisions in discontinuing mechanical ventilation. N Engl J Med. 1988 Apr 14; 318(15):984-8. PMID: 3352689.
      View in: PubMed
    61. Hyslop PA, Hinshaw DB, Halsey WA, Schraufstätter IU, Sauerheber RD, Spragg RG, Jackson JH, Cochrane CG. Mechanisms of oxidant-mediated cell injury. The glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide. J Biol Chem. 1988 Feb 05; 263(4):1665-75. PMID: 3338986.
      View in: PubMed
    62. Smith RM, Spragg RG, Moser KM, Cochrane CG, McCarren JP. Pulmonary penetration of alpha 1-proteinase inhibitor administered parenterally to dogs. Am Rev Respir Dis. 1987 Dec; 136(6):1391-6. PMID: 3120632.
      View in: PubMed
    63. Spragg RG, Schraufstatter IU, Hyslop PA, Hinshaw DB, Cochrane CG. Oxidant injury of cultured cells: biochemical consequences. Prog Clin Biol Res. 1987; 236A:253-8. PMID: 3112791.
      View in: PubMed
    64. Smith RM, Spragg RG, Moser KM. Biologic availability of injected or aerosolized alpha 1 proteinase inhibitor. Prog Clin Biol Res. 1987; 236A:203-10. PMID: 3497405.
      View in: PubMed
    65. Hyslop PA, Hinshaw DB, Schraufstätter IU, Sklar LA, Spragg RG, Cochrane CG. Intracellular calcium homeostasis during hydrogen peroxide injury to cultured P388D1 cells. J Cell Physiol. 1986 Dec; 129(3):356-66. PMID: 3782310.
      View in: PubMed
    66. Schraufstatter IU, Hyslop PA, Hinshaw DB, Spragg RG, Sklar LA, Cochrane CG. Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc Natl Acad Sci U S A. 1986 Jul; 83(13):4908-12. PMID: 2941760.
      View in: PubMed
    67. Hinshaw DB, Sklar LA, Bohl B, Schraufstatter IU, Hyslop PA, Rossi MW, Spragg RG, Cochrane CG. Cytoskeletal and morphologic impact of cellular oxidant injury. Am J Pathol. 1986 Jun; 123(3):454-64. PMID: 3717299.
      View in: PubMed
    68. Schraufstatter IU, Hinshaw DB, Hyslop PA, Spragg RG, Cochrane CG. Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide. J Clin Invest. 1986 Apr; 77(4):1312-20. PMID: 2937805.
      View in: PubMed
    69. Spragg RG, Hinshaw DB, Hyslop PA, Schraufstätter IU, Cochrane CG. Alterations in adenosine triphosphate and energy charge in cultured endothelial and P388D1 cells after oxidant injury. J Clin Invest. 1985 Oct; 76(4):1471-6. PMID: 2997279.
      View in: PubMed
    70. Bickler PE, Spragg RG, Hartman MT, White FN. Distribution of ventilation in American alligator Alligator mississippiensis. Am J Physiol. 1985 Oct; 249(4 Pt 2):R477-81. PMID: 4051034.
      View in: PubMed
    71. Schraufstätter IU, Hinshaw DB, Hyslop PA, Spragg RG, Cochrane CG. Glutathione cycle activity and pyridine nucleotide levels in oxidant-induced injury of cells. J Clin Invest. 1985 Sep; 76(3):1131-9. PMID: 3840176.
      View in: PubMed
    72. Krieger BP, Loomis WH, Czer GT, Spragg RG. Mechanisms of interaction between oxygen and granulocytes in hyperoxic lung injury. J Appl Physiol (1985). 1985 Apr; 58(4):1326-30. PMID: 3838744.
      View in: PubMed
    73. Hallman M, Arjomaa P, Tahvanainen J, Lachmann B, Spragg R. Endobronchial surface active phospholipids in various pulmonary diseases. Eur J Respir Dis Suppl. 1985; 142:37-47. PMID: 3860395.
      View in: PubMed
    74. Lichter JP, Konopka RG, Hartman MT, Moser KM, Spragg RG. The in vivo behavior of granulocytes labeled with indium-111 in a canine model of pneumococcal pneumonia. Am Rev Respir Dis. 1984 Apr; 129(4):602-6. PMID: 6712001.
      View in: PubMed
    75. Krieger B, Schwartz J, Loomis W, Marsh J, Spragg R. Nonspecificity of elevated angiotensin-converting enzyme activity in bronchoalveolar lavage fluid from high permeability lung edema states. Am Rev Respir Dis. 1984 Mar; 129(3):499-500. PMID: 6322628.
      View in: PubMed
    76. Schwartz JS, Konopka RG, Spragg RG. Effect of histamine and propranolol on extravascular lung water. Am J Physiol. 1984 Jan; 246(1 Pt 2):H69-73. PMID: 6696090.
      View in: PubMed
    77. Krieger BP, Loomis WH, Spragg RG. Granulocytes and hyperoxia act synergistically in causing acute lung injury. Exp Lung Res. 1984; 7(2):77-83. PMID: 6525983.
      View in: PubMed
    78. Moser KM, Spragg RG, Utley J, Daily PO. Chronic thrombotic obstruction of major pulmonary arteries. Results of thromboendarterectomy in 15 patients. Ann Intern Med. 1983 Sep; 99(3):299-304. PMID: 6614679.
      View in: PubMed
    79. Spragg RG, Wolf PL, Haghighi P, Abraham JL, Astarita RW. Angiosarcoma of the lung with fatal pulmonary hemorrhage. Am J Med. 1983 Jun; 74(6):1072-6. PMID: 6683073.
      View in: PubMed
    80. Cochrane CG, Spragg RG, Revak SD, Schraufstatter I. Biochemical factors in pulmonary inflammatory disease. Chest. 1983 May; 83(5 Suppl):67S-70S. PMID: 6340987.
      View in: PubMed
    81. Cochrane CG, Spragg R, Revak SD. Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid. J Clin Invest. 1983 Mar; 71(3):754-61. PMID: 6600748.
      View in: PubMed
    82. Cochrane CG, Spragg RG, Revak SD, Cohen AB, McGuire WW. The presence of neutrophil elastase and evidence of oxidation activity in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am Rev Respir Dis. 1983 Feb; 127(2):S25-7. PMID: 6550478.
      View in: PubMed
    83. Moser KM, Spragg RG. Use of the balloon-tipped pulmonary artery catheter in pulmonary disease. Ann Intern Med. 1983 Jan; 98(1):53-8. PMID: 6848045.
      View in: PubMed
    84. Utley JR, Spragg RG, Long WB, Moser KM. Pulmonary endarterectomy for chronic thromboembolic obstruction: recent surgical experience. Surgery. 1982 Dec; 92(6):1096-102. PMID: 7147187.
      View in: PubMed
    85. Spragg RG, Benumof JL, Alfery DD. New methods for the performance of unilateral lung lavage. Anesthesiology. 1982 Dec; 57(6):535-8. PMID: 7149310.
      View in: PubMed
    86. Hooper WW, Slutsky RA, Kocienski DE, Witztum KF, Spragg RG, Ashburn WL, Moser KM. Right and left ventricular response to subcutaneous terbutaline in patients with chronic obstructive pulmonary disease: radionuclide angiographic assessment of cardiac size and function. Am Heart J. 1982 Nov; 104(5 Pt 1):1027-32. PMID: 7136993.
      View in: PubMed
    87. Hallman M, Spragg R, Harrell JH, Moser KM, Gluck L. Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J Clin Invest. 1982 Sep; 70(3):673-83. PMID: 6896715.
      View in: PubMed
    88. McEvoy RD, Davies NJ, Hedenstierna G, Hartman MT, Spragg RG, Wagner PD. Lung mucociliary transport during high-frequency ventilation. Am Rev Respir Dis. 1982 Sep; 126(3):452-6. PMID: 6751174.
      View in: PubMed
    89. Spragg RG, Abraham JL, Loomis WH. Pulmonary platelet deposition accompanying acute oleic-acid-induced pulmonary injury. Am Rev Respir Dis. 1982 Sep; 126(3):553-7. PMID: 7125342.
      View in: PubMed
    90. Shure D, Spragg RG, Moser KM. Large cavitary dead space as an unusual cause of hypercapnic respiratory failure in pulmonary tuberculosis. Thorax. 1982 Jul; 37(7):550-1. PMID: 7135301.
      View in: PubMed
    91. McGuire WW, Spragg RG, Cohen AB, Cochrane CG. Studies on the pathogenesis of the adult respiratory distress syndrome. J Clin Invest. 1982 Mar; 69(3):543-53. PMID: 7037851.
      View in: PubMed
    92. Lane TA, Bergum PW, Lichter JP, Spragg RG. The labeling of rabbit neutrophils with [111In]oxine. J Immunol Methods. 1982; 51(3):293-305. PMID: 6809833.
      View in: PubMed
    93. Moser KM, LeMoine JR, Nachtwey FJ, Spragg RG. Deep venous thrombosis and pulmonary embolism. Frequency in a respiratory intensive care unit. JAMA. 1981 Sep 25; 246(13):1422-4. PMID: 7265445.
      View in: PubMed
    94. Moser KM, Spragg RG, Bender F, Konopka R, Hartman MT, Fedullo P. Study of factors that may condition scintigraphic detection of venous thrombi and pulmonary emboli with indium-111-labeled platelets. J Nucl Med. 1980 Nov; 21(11):1051-8. PMID: 7431104.
      View in: PubMed
    95. Spragg RG, Ackerman R, White FN. Distribution of ventilation in the turtle Pseudemys scripta. Respir Physiol. 1980 Oct; 42(1):73-87. PMID: 7444225.
      View in: PubMed
    96. Neuman TS, Spragg RG, Wagner PD, Moser KM. Cardiopulmonary consequences of decompression stress. Respir Physiol. 1980 Aug; 41(2):143-53. PMID: 6776599.
      View in: PubMed
    97. Hill RN, Spragg RG, Wedel MK, Moser KM. Letter: Adult respiratory distress syndrome associated with colchicine intoxication. Ann Intern Med. 1975 Oct; 83(4):523-4. PMID: 1166987.
      View in: PubMed
    98. Spragg RG, Hill RN, Wedel MK, Materson A, Moser KM. Platelet kinetics in venovenous membrane oxygenation. Trans Am Soc Artif Intern Organs. 1975; 21:171-7. PMID: 1145990.
      View in: PubMed
    99. Hill RN, Shibel EM, Spragg RG, Moser KM. Adult respiratory distress syndrome: early predictors of mortality. Trans Am Soc Artif Intern Organs. 1975; 21:199-205. PMID: 1145992.
      View in: PubMed